CTLA4 and neoplasm: In recent years, many findings have confirmed that immunosuppressive molecules such as cytotoxic T lymphocyte-associated antigen 4 (CTLA4), PD-1and its ligand PD-L1 are seen to be significantly overexpressed in the immune microenvironment of tumor patients (Mellman et al., 2011).